Moderna – “Over the next three years, we expect to build a large seasonal vaccine franchise”

by

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026

Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028

Over the next three years, we expect to build a large seasonal vaccine franchise for at-risk populations and invest the cash generated into oncology and rare disease therapeutics,” said Stéphane Bancel, CEO of Moderna.

https://feeds.issuerdirect.com/news-release.html?newsid=5758345706655596&symbol=MRNA

h/t A Deplorable Neanderthal